Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."

TSX:MSL - Post Discussion

MERUS LABS INTERNATIONAL INC > James Hodgins(Curvature Hedge)
View:
Post by power_auditor on Apr 21, 2014 6:49pm

James Hodgins(Curvature Hedge)

Likes the metrics here over CXR(Concordia)....if I heard correctly,is now shorting CXR and going long MSL.... the more exposure we(MSL) receive can only benefit the share price...sector seems to be in favour for now.    Volume is kinda low....maybe the Valeant news tonight with Ackerman, will light a spark  here for people looking for some ideals....in small caps....GLTA

****James is on BNN mkt call tonight(Apr.21/14)
Comment by lscfa on Apr 21, 2014 6:51pm
He said the the EV/EBITDA ratio for CXR is 12x vs. 5x for MSL. Thus the pair trade.
Comment by retiredcf on Apr 22, 2014 8:49am
Second stock in the clip + two sets of comments. GLTA https://watch.bnn.ca/#clip1081536Merus Labs International (MSL TSX) Last Purchase: 2 weeks ago at $1.65 Recent capital raise will enable an acquisition that drives growth and diversifies the company's revenues. This should result in a rerating of the shares more in line with its competition. At only five times EV/Ebitda the company trades ...more  
Comment by onacom on May 24, 2014 9:49am
I hope he shorted CXR, when you wrote your post, he did very well, may be he should start covering... but not such a luck, when you get blocks of 5G, 10G. 30G on the buy side, and no sellers.. I own both, and still staying long CXR, MSL, DND, RX good luck all.....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities